NCT06102915View on ClinicalTrials.gov

Rocuronium vs Cis-atracurium: Do Rocuronium Still 'ROCKS' In Coronary Artery Bypass Grafting

CompletedOBSERVATIONAL
Enrollment

289

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

November 23, 2023

Study Completion Date

November 23, 2023

Conditions
Neuromuscular BlockadePostoperative Pulmonary AtelectasisPostoperative Pulmonary ComplicationCoronary Artery DiseaseCoronary Artery Bypass GraftingHypothermic Cardiopulmonary Bypass
Interventions
DRUG

Rocuronium Bromide 10 MG/ML

Comparative

DRUG

Nimbex 10 MG in 5 ML Injection

Comparative

Trial Locations (1)

50400

Institut Jantung Negara, Kuala Lumpur

All Listed Sponsors
lead

Institut Jantung Negara

OTHER

NCT06102915 - Rocuronium vs Cis-atracurium: Do Rocuronium Still 'ROCKS' In Coronary Artery Bypass Grafting | Biotech Hunter | Biotech Hunter